BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 22691960)

  • 1. Nanoparticle analysis of circulating cell-derived vesicles in ovarian cancer patients.
    Gercel-Taylor C; Atay S; Tullis RH; Kesimer M; Taylor DD
    Anal Biochem; 2012 Sep; 428(1):44-53. PubMed ID: 22691960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis.
    Dragovic RA; Gardiner C; Brooks AS; Tannetta DS; Ferguson DJ; Hole P; Carr B; Redman CW; Harris AL; Dobson PJ; Harrison P; Sargent IL
    Nanomedicine; 2011 Dec; 7(6):780-8. PubMed ID: 21601655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of exosomes derived from ovarian cancer cells and normal ovarian epithelial cells by nanoparticle tracking analysis.
    Zhang W; Peng P; Kuang Y; Yang J; Cao D; You Y; Shen K
    Tumour Biol; 2016 Mar; 37(3):4213-21. PubMed ID: 26490993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor accumulation of NIR fluorescent PEG-PLA nanoparticles: impact of particle size and human xenograft tumor model.
    Schädlich A; Caysa H; Mueller T; Tenambergen F; Rose C; Göpferich A; Kuntsche J; Mäder K
    ACS Nano; 2011 Nov; 5(11):8710-20. PubMed ID: 21970766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immuno-characterization of Exosomes Using Nanoparticle Tracking Analysis.
    McNicholas K; Michael MZ
    Methods Mol Biol; 2017; 1545():35-42. PubMed ID: 27943205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates.
    Filipe V; Hawe A; Jiskoot W
    Pharm Res; 2010 May; 27(5):796-810. PubMed ID: 20204471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing.
    van der Pol E; Coumans FA; Grootemaat AE; Gardiner C; Sargent IL; Harrison P; Sturk A; van Leeuwen TG; Nieuwland R
    J Thromb Haemost; 2014 Jul; 12(7):1182-92. PubMed ID: 24818656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy.
    Sokolova V; Ludwig AK; Hornung S; Rotan O; Horn PA; Epple M; Giebel B
    Colloids Surf B Biointerfaces; 2011 Oct; 87(1):146-50. PubMed ID: 21640565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interference from Proteins and Surfactants on Particle Size Distributions Measured by Nanoparticle Tracking Analysis (NTA).
    Bai K; Barnett GV; Kar SR; Das TK
    Pharm Res; 2017 Apr; 34(4):800-808. PubMed ID: 28155075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical challenges of extracellular vesicle detection: A comparison of different techniques.
    Erdbrügger U; Lannigan J
    Cytometry A; 2016 Feb; 89(2):123-34. PubMed ID: 26651033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle Tracking Analysis for Multiparameter Characterization and Counting of Nanoparticle Suspensions.
    Griffiths D; Carnell-Morris P; Wright M
    Methods Mol Biol; 2020; 2118():289-303. PubMed ID: 32152988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of membrane vesicles in tumorigenesis.
    Pap E; Pállinger E; Falus A
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):213-23. PubMed ID: 20884225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence-Based Nanoparticle Tracking Analysis and Flow Cytometry for Characterization of Endothelial Extracellular Vesicle Release.
    Oesterreicher J; Pultar M; Schneider J; Mühleder S; Zipperle J; Grillari J; Holnthoner W
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proinvasive properties of ovarian cancer ascites-derived membrane vesicles.
    Graves LE; Ariztia EV; Navari JR; Matzel HJ; Stack MS; Fishman DA
    Cancer Res; 2004 Oct; 64(19):7045-9. PubMed ID: 15466198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Particle Sizing of Nanoparticle Adjuvant Formulations by Dynamic Light Scattering (DLS) and Nanoparticle Tracking Analysis (NTA).
    Chan MY; Dowling QM; Sivananthan SJ; Kramer RM
    Methods Mol Biol; 2017; 1494():239-252. PubMed ID: 27718198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel test for microparticles in platelet-rich plasma and platelet concentrates using dynamic light scattering.
    Xu Y; Nakane N; Maurer-Spurej E
    Transfusion; 2011 Feb; 51(2):363-70. PubMed ID: 20723171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microparticle sizing by dynamic light scattering in fresh-frozen plasma.
    Lawrie AS; Albanyan A; Cardigan RA; Mackie IJ; Harrison P
    Vox Sang; 2009 Apr; 96(3):206-12. PubMed ID: 19175566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Extracellular Vesicles Using Fluorescence Nanoparticle Tracking Analysis.
    Carnell-Morris P; Tannetta D; Siupa A; Hole P; Dragovic R
    Methods Mol Biol; 2017; 1660():153-173. PubMed ID: 28828655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodal Dispersion of Nanoparticles: A Comprehensive Evaluation of Size Distribution with 9 Size Measurement Methods.
    Varenne F; Makky A; Gaucher-Delmas M; Violleau F; Vauthier C
    Pharm Res; 2016 May; 33(5):1220-34. PubMed ID: 26864858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticle tracking analysis versus dynamic light scattering: Case study on the effect of Ca
    Hou J; Ci H; Wang P; Wang C; Lv B; Miao L; You G
    J Hazard Mater; 2018 Oct; 360():319-328. PubMed ID: 30125748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.